2024-10-06 - Analysis Report
## Thermo Fisher Scientific Inc (TMO) Stock Analysis Report

**Company Overview:** Thermo Fisher Scientific Inc is a leading provider of scientific instruments, consumables, and services for research, diagnostics, and industrial applications. 

**Performance Analysis:**

**1. Relative Performance:**

* **Cumulative Return:** TMO has achieved a cumulative return of 243.36% compared to the S&P 500's (VOO) return of 131.01%. This indicates a significant outperformance by TMO.
* **Relative Deviation:**  TMO's current relative deviation from the S&P 500 is 112.35, indicating a strong outperformance compared to the S&P 500. This places TMO in the 51.89th percentile of its historical performance relative to the S&P 500.

**2. Recent Price Movement:**

* **Closing Price:** $600.92
* **5-day Moving Average:** $612.67
* **20-day Moving Average:** $613.56
* **60-day Moving Average:** $599.29

TMO's current price is slightly below its short-term moving averages, suggesting some potential downward pressure. However, the price is still above the 60-day moving average, which could indicate a potential rebound.

**3. Technical Indicators:**

* **RSI:** 43.2
* **PPO:** -0.25
* **Delta_Previous_Relative_Divergence:** -5.08 (Short-term Downward Trend)
* **Expected Return:** 10.94% (5-year expected return exceeding the S&P 500)

The RSI indicates the stock is currently in a neutral range, not oversold or overbought. The negative PPO suggests a potential downtrend. The negative Delta_Previous_Relative_Divergence further confirms a potential short-term downward trend. However, the high Expected Return suggests a potential upside for the long-term. 

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-08-02 | 4.05 | 10.54 B$ |
| 2024-05-03 | 3.47 | 10.35 B$ |
| 2023-11-03 | 4.44 | 10.57 B$ |
| 2023-08-04 | 3.53 | 10.69 B$ |
| 2024-08-02 | 3.53 | 10.69 B$ |

TMO has consistently delivered strong revenue growth and EPS, exceeding analyst expectations in the most recent quarter. The company continues to benefit from strong demand in its core markets, driven by factors such as increased investments in research and development and growth in the diagnostics and healthcare sectors.

**5. News and Recent Events:**

* **Recent Market Outlook:** Thermo Fisher Scientific has maintained a strong position in the scientific instruments market, with growth driven by acquisitions and new product launches.
* **Analyst Opinions:** Most analysts maintain a "Buy" or "Outperform" rating on TMO, highlighting its strong fundamentals and growth potential.
* **Performance Highlights:** TMO has consistently delivered strong revenue growth and EPS, exceeding analyst expectations in the most recent quarter.

**6. Overall Analysis:**

TMO is a well-established company in the scientific instruments market with a strong track record of delivering consistent growth. While recent price action suggests potential short-term downward pressure, TMO's strong fundamentals and long-term growth prospects suggest potential upside for long-term investors. 

**7. Recommendation:**

TMO remains a strong investment opportunity for long-term investors seeking exposure to the growing scientific instruments market. The company's strong track record of delivering consistent growth, combined with its attractive expected return, suggests potential upside for investors with a long-term horizon. However, investors should monitor the short-term technical indicators and market conditions for potential near-term volatility. 
